Adaptimmune Therapeutics
ADAP
#9234
Rank
ยฃ54.61 M
Marketcap
ยฃ0.21
Share price
4.45%
Change (1 day)
-77.35%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -ยฃ0.45

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.40. In 2022 the company made an earnings per share (EPS) of -ยฃ0.76 a decrease over its 2021 EPS that were of -ยฃ0.76.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.45-40.2%
2022-ยฃ0.76-0%
2021-ยฃ0.766.25%
2020-ยฃ0.71-27.27%
2019-ยฃ0.9829.41%
2018-ยฃ0.7620.09%
2017-ยฃ0.63-16.73%
2016-ยฃ0.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ5.35 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.70 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.93 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ0.21-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA